ClinicalTrials.Veeva

Menu

EPT 100: Geranium Oil for the Relief of Neuropathic Pain

Pennington Biomedical Research Center logo

Pennington Biomedical Research Center

Status

Completed

Conditions

Neuropathic Pain

Treatments

Other: Geranium oil

Study type

Interventional

Funder types

Other

Identifiers

NCT01007747
PBRC 21033

Details and patient eligibility

About

The purpose of this study is to determine if Geranium oil will relieve a variety of neuropathic pain and some pain relief will last more than 48 hours.

Full description

EPT 100 study is designed to identify the percentage of people who experience neuropathic pain relief from topical geranium oil from Reunion Island, determine which neuropathic pain conditions respond best and define the time course of the pain relief.

Enrollment

166 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or oler
  • Neuralgia or neuropathy with daily pain
  • At least moderate intensity pain
  • Signed informed consent

Exclusion criteria

  • Pregnant or nursing
  • Known allergies to geranium oil or geranium oil fractions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

166 participants in 1 patient group

Geranium oil
Experimental group
Treatment:
Other: Geranium oil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems